Inovio Pharmaceuticals Inc. Stock Advances 4.7%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Inovio Pharmaceuticals Inc. rallied 4.7% to $1.33 on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.

Inovio Pharmaceuticals Inc. closed 55.4% short of its 52-week high of $2.98, which the company achieved on September 9th.

The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. rose 0.32% to $28.55.

Trading volume totaled 2.6 million, compared to the 50-day average of 3.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

September 01, 2026 16:34 ET (20:34 GMT)